Health Care & Life Sciences » Pharmaceuticals | Miraca Holdings Inc.

Miraca Holdings Inc. | Balance Sheet

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
36,349
27,922
32,255
36,044
20,455
33,699
Total Accounts Receivable
35,037
36,321
35,560
34,789
32,310
34,754
Inventories
14,281
14,912
14,836
14,277
14,541
15,943
Other Current Assets
9,508
10,920
11,376
7,651
10,452
5,250
Total Current Assets
95,175
90,075
94,027
92,763
77,761
89,649
Net Property, Plant & Equipment
40,867
42,537
40,277
38,055
48,807
54,753
Total Investments and Advances
3,159
17,904
15,227
13,103
14,274
14,648
Intangible Assets
96,174
103,989
75,409
56,716
11,368
15,098
Other Assets
3,797
4,377
6,844
6,787
8,518
12,833
Total Assets
242,159
262,203
237,296
213,926
176,068
201,234
ST Debt & Current Portion LT Debt
5,223
6,836
16,822
2,746
2,643
Accounts Payable
11,327
11,811
11,161
10,359
10,562
Income Tax Payable
5,332
4,122
1,076
2,861
1,200
Other Current Liabilities
18,273
20,110
20,844
21,213
27,112
Total Current Liabilities
40,155
42,879
49,903
37,179
41,517
Long-Term Debt
23,095
27,559
10,911
8,584
5,459
Provision for Risks & Charges
7,325
5,232
4,883
3,170
14,130
Deferred Taxes
7,890
7,408
3,377
1,462
15,293
Other Liabilities
3,359
3,953
7,010
8,940
1,686
Total Liabilities
84,811
90,352
81,596
65,835
62,838
Common Equity (Total)
157,348
171,851
155,700
148,087
113,225
Total Shareholders' Equity
157,348
171,851
155,700
148,087
113,225
Total Equity
157,348
171,851
155,700
148,087
113,225
Liabilities & Shareholders' Equity
242,159
262,203
237,296
213,922
176,063

About Miraca Holdings

View Profile
Address
Shinjuku Mitsui Building, 8/F
Tokyo Tokyo 163
Japan
Employees -
Website http://www.miraca-holdings.co.jp
Updated 07/08/2019
Miraca Holdings Inc. operates as a holding company which provides the strategic planning, investor relations, public relations, and supervisory management of the entire group. It operates through the following segments: In Vitro Diagnostics, Clinical Laboratory Testing, and Healthcare Related. The In Vitro Diagnostic segment offers clinical laboratory testing services; collecting consigned specimens of patients from medical institutions, conducting analyses and reporting the test results back.